Patent intelligence · US
US 7183255
Method for stabilizing blood pressure in hemodialysis subjects
Method for stabilizing blood pressure in hemodialysis subjects
Patent details — US 7183255
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 27, 2007
- Expiration
- Feb 22, 2027
- Applicant
- Intradialytic Pharmaceuticals
- Claims
- 13
- CPC classes
- A61K, A61K38/095
Quick answer
US 7183255 (Method for stabilizing blood pressure in hemodialysis subjects) is held by Intradialytic Pharmaceuticals. Status: granted. Granted Feb 27, 2007. Expires Feb 22, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Intradialytic Pharmaceuticals
- Grant date
- Expiration
- Claims
- 13
- CPC classes
- A61K, A61K38/095
Frequently asked questions
What is US patent 7183255?
US 7183255 (Method for stabilizing blood pressure in hemodialysis subjects) is held by Intradialytic Pharmaceuticals. Status: granted. Granted Feb 27, 2007. Expires Feb 22, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7183255?
Intradialytic Pharmaceuticals is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1 pharmaceutical patents for this assignee.
When does US 7183255 expire?
Our index shows an expiration date of Feb 22, 2027 (1 year from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.